Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
These agents mimic the action of glucagon-like peptide-1, stimulating insulin secretion, slowing gastric emptying, and promoting satiety
Epigenetics 8 , 111 (2016)
Protocol : BPC-157: 500 mcg/day (near injury or systemic) CJC-1295 w/ DAC: 2 mg twice per week Ipamorelin: 100200 mcg, 12x/day Duration: 68 weeks max Stacking Summary Potential Side Effects and Safety Profile of BPC-157 Compared to most performance-enhancing drugs, peptides, or even over-the-counter recovery aids, BPC-157 is remarkably well-tolerated
While weight gaining in the PTU and LC group agrees with Abd-Elrazek and Ahmed-Farid 12 who injected 5 rats with LC for 28 days at a dose of 350 mg/kg after receiving busulfan (anti-cancer drug that causes infertility) and stated that rat body weight increased on administration of LC against the anti-cancer therapy
Early trial data shows weight loss exceeding 24% at higher doses
J Exp Clin Cancer Res
US$ 29.07
US$ 21.45
US$ 27.25
US$ 24.66
